SEC Comment Letter for ARGENX SE (ARGX) (CIK 0001697862) (ARGX) — May 17, 2017
ARGENX SE (ARGX) (CIK 0001697862)
Date: May 17, 2017 · CIK: 0001697862 · Accession: 0000000000-17-017342
AI Filing Summary & Sentiment
File numbers found in text: 333-217417
Show Raw Text
Mail Stop 4546
May 16, 2017
Tim Van Hauwermeiren
Chief Executive Officer
argenx SE
Willemstraat 5
4811 AH, Breda, the Netherlands
Re: argenx SE
Amendment No. 3 to
Registration Statement on Form F -1
Filed May 16, 2017
File No. 333-217417
Dear Mr. Van Hauwermeiren:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not bel ieve an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.
Exhibit 5.1
1. Please rem ove the limitation in Section 3(o): Jurisdiction on page 4 of the opinion . In the
alternative, please explain how the limitation is consistent with Section 14 of the
Securities Act.
Tim Van Hauwermeiren
argenx SE
May 16, 2017
Page 2
You may contact Sasha Parikh at (202) 551 -3627 or Kevin Vaughn, Accounting Branch
Chief, at (202) 551 -3494 if you have questions regarding comments on the financial statements
and related matters. Please contact Ada D. Sarmento at (202) 551 -3798 or Erin Jaskot, Special
Counsel, at (202) 551 -3442 with any other questio ns.
Sincerely,
/s/ Erin K. Jaskot, for
Suzanne Hayes
Assistant Director
Office of Healthcare and Insurance
cc: Edwin O’Connor
Goodwin Procter LLP